Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-29

Clinical Trial Update: Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy with or without cisplatin for recurrent endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)

Snippet

Sponsor: GOG Foundation | Conditions: Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Mucinous Adenocarcinoma | Phase 2 | Status: UNKNOWN | Results posted: 2023-03-29